Document Detail

Is ranibizumab effective in stopping the loss of vision for choroidal neovascularisation in pathologic myopia? A long-term follow-up study.
MedLine Citation:
PMID:  20935305     Owner:  NLM     Status:  In-Data-Review    
Aim To assess the efficacy and safety of ranibizumab in the treatment of choroidal neovascularisation (CNV) caused by pathologic myopia (PM). Design Prospective, multicentre, interventional case series. Methods 40 eyes of 39 consecutive patients with PM and CNV were treated with 'on demand' intravitreal injection of ranibizumab 0.5 mg. Final best corrected visual acuity (BCVA) and its change from baseline were the main outcome measures. Changes in optical coherence tomography (OCT) central retinal thickness (CRT) were a secondary outcome. Results Mean age was 53±13 years and mean refractive error -13.5±6.5 D. Median follow-up was 13.3±2 (range 12-18) months. Fifteen eyes (37.5%) had previously been treated with photodynamic therapy (PDT). The mean baseline logarithm of the minimum angle of resolution (logMAR) BCVA (Early Treatment Diabetic Retinopathy Study (ETDRS) vision chart) was 0.68±0.34 (Snellen equivalent 20/131) and 21±16 letters. The final mean logMAR BCVA was 0.27±0.2 (p = 0.008) (20/42) and 40.5±14 letters (p = 0.01). Mean final VA improved in 82.5% of patients, in 60% by 3 or more lines (median number of lines gained 2.9). Even six out of seven cases of low vision (≤1.1 logMAR) at the final examination has improved vision. Mean OCT CRT reduced from 218±70 to 175±46 μm (p 0.02). Age and previous PDT did not influence the results (p>0.05). The mean number of injection was 2.8±1.2 (range 1-6). No ocular or systemic side effects were observed. Conclusion Ranibizumab was an effective treatment for stabilising and improving vision with a low number of injections in 92.5% of patients with myopic CNV in a long-term follow-up.
Maria Vadalà; Alfredo Pece; Stefano Cipolla; Carla Monteleone; Giuseppe Fasolino; Alessandra Casuccio; Salvatore Cillino
Related Documents :
11011705 - Scleral buckling for stage 4 retinopathy of prematurity.
1143085 - Benign intracranial hypertension.
24148685 - Follow-up outcomes of self-expanding stents for carotid artery angioplasty at a single ...
18235025 - Influence of intraoperative course on visual outcome after an rpe-choroid translocation.
718805 - The treatment of uterine bleeding with vasopressin hormonogen (glypressin)--a pilot study.
20737055 - Over-treated corneal abscess may be toxic keratopathy.
Publication Detail:
Type:  Journal Article     Date:  2010-10-08
Journal Detail:
Title:  The British journal of ophthalmology     Volume:  95     ISSN:  1468-2079     ISO Abbreviation:  Br J Ophthalmol     Publication Date:  2011 May 
Date Detail:
Created Date:  2011-04-21     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0421041     Medline TA:  Br J Ophthalmol     Country:  England    
Other Details:
Languages:  eng     Pagination:  657-61     Citation Subset:  IM    
Dipartimento di Neuroscienze Cliniche, Sezione di Oftalmologia, Università di Palermo, via L. Giuffrè 13, 90127 Palermo, Italy;
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Marked remodelling of the anterior corneal surface following collagen cross-linking with riboflavin ...
Next Document:  Evaluation of factors influencing distance stereoacuity on Frisby-Davis Distance Test (FD2) in inter...